India’s specialty chemicals sector is experiencing rapid growth, with a market size projected to reach $64 billion by 2025, driven by a CAGR of 12 percent. The industry has grown significantly from $27 billion in 2018, driven by domestic demand and exports, positioning India as a key global player.
Price Movement
With a market capitalization of Rs 8,573.00 crore, the shares of Anupam Rasayan India Ltd closed at Rs 779.85 per share, decreased around 0.33 percent as compared to the previous closing price of Rs 782.45 apiece.
Matter Explanation
Anupam Rasayan India Ltd expects a 30-35 percent revenue growth in FY ’26, driven by strong demand in Pharma and Polymer segments. Growth will be fueled by new product commercialization and a robust Rs 10,700 crore order book, ensuring sustained performance in the coming years.
Financial performance
In Q3 FY ’25, consolidated revenue rose 32 percent YoY to Rs 390 crores, EBITDA grew 48 percent to Rs 121 crores (31 percent margin, up 389 bps), and PAT surged 108 percent to Rs 54 crores. However, for the nine months ending Dec 31, 2024, revenue fell 13 percent YoY to Rs 938 crores, with EBITDA down 14 percent to Rs 262 crores.
Growth Drivers
Anupam’s growth is driven by 17+ molecule launches in FY24 and 6+ planned for FY25, with 65+ in R&D. The Tanfac acquisition strengthens its fluorination chemistry with a stable KF and HF supply. Japan, backed by long-term contracts, is set to contribute one-third of sales in 2-3 years.
Capex and Sustainability Initiatives
The company has completed Rs 650 crores of its Rs 670 crores capex, with all plants set for commercialization by March 31, 2025. A Rs 59 crores investment in a 9.2 MW hybrid power plant will save Rs 15 crores annually. It targets 65 percent of its electricity from green energy.
Also read: Mukul Agrawal stock jumps after receiving $606,000 brass billets order from Dubai-based Co.
Margin Guidance
The company expects EBITDA margins to stay stable between 26% and 28%, with a potential upward trend driven by improvements in the product mix. This stability reflects a strong operational outlook, ensuring profitability remains consistent while leveraging better product positioning for incremental gains.
Working Capital and Debt Management
As of December 31, 2024, the company’s total debt stands at approximately ₹1,200 crores, reduced through term loan repayments. It plans to lower working capital days to 180-200 over
the next 18 months, expecting improved cash flow as sales grow. This strategic focus aims to enhance financial stability and operational efficiency.
Company Profile
Anupam Rasayan India Limited is engaged in the custom synthesis and manufacturing of specialty chemicals in India. The Company’s segments include Life Science Related Specialty Chemicals and Other Specialty Chemicals.
Written by Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
